Transcriptomics

Dataset Information

0

Dual Antimicrobial and Anti-inflammatory Activity of a Nitric Oxide-releasing Topical Medication in Atopic Dermatitis

ABSTRACT: A clinical trial assessed the cutaneous immune response and short-term efficacy, safety, and tolerability in adults with mild to moderate AD who applied SB414 2% and 6% BID for 2 weeks.

ORGANISM(S): Homo sapiens

PROVIDER: GSE141571 | GEO | 2020/11/23

REPOSITORIES: GEO

Json Xml

Similar Datasets

Genomics Dual Antimicrobial and Anti-inflammatory Activity of a Nitric Oxide-releasing Topical Medication in Atopic Dermatitis
| PRJNA593988 | ENA
Unknown Mimicking the Endothelium: Dual Action Heparinized Nitric Oxide Releasing Surface.
| S-EPMC7962625 | biostudies-literature
Unknown Nitric Oxide-Releasing Cyclodextrins.
| S-EPMC6790977 | biostudies-literature
Unknown Nitric Oxide-Releasing Alginates.
| S-EPMC6759059 | biostudies-literature
Unknown Process utilities for topical treatment in atopic dermatitis.
| S-EPMC6698259 | biostudies-literature
Unknown Crisaborole: A Novel Nonsteroidal Topical Treatment for Atopic Dermatitis.
| S-EPMC6600556 | biostudies-literature
Unknown Topical treatment with SPHINGOLIPIDS and GLYCOSAMINOGLYCANS for canine atopic dermatitis.
| S-EPMC7082980 | biostudies-literature
Unknown Nitric oxide-releasing porous silicon nanoparticles.
| S-EPMC4109794 | biostudies-literature
Unknown Nitric oxide-releasing electrospun polymer microfibers.
| S-EPMC3045468 | biostudies-literature
Unknown SB206, a Nitric Oxide-Releasing Topical Medication, Induces the Beginning of the End Sign and Molluscum Clearance.
| S-EPMC8659381 | biostudies-literature